Clinical Trial Update: Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database

View source ↗

Summary

This clinical trial update reports real-world outcomes for patients with advanced melanoma treated with the nivolumab and relatlimab combination, using the Flat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Melanoma | Status: COMPLETED